1. Home
  2. Labeler Index
  3. Brigham And Women`s Hospital, Inc., The
  4. 24450-647
  5. NDC Package Code: 24450-647-30 Fludeoxyglucose F-18

NDC Package 24450-647-30 Fludeoxyglucose F-18

Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
24450-647-30
Package Description:
30 mL in 1 VIAL, MULTI-DOSE
Product Code:
24450-647
Proprietary Name:
Fludeoxyglucose F-18
Non-Proprietary Name:
Fludeoxyglucose F-18
Substance Name:
Fludeoxyglucose F-18
Usage Information:
Fludeoxyglucose F18 Injection is indicated for positron emission tomography (PET) imaging in the following settings:
11-Digit NDC Billing Format:
24450064730
Product Type:
Human Prescription Drug
Labeler Name:
Brigham And Women`s Hospital, Inc., The
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • FLUDEOXYGLUCOSE F-18 300 mCi/mL
    • Pharmacologic Class(es):
  • Radioactive Diagnostic Agent - [EPC] (Established Pharmacologic Class)
  • Radiopharmaceutical Activity - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA203816
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-30-2014
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 24450-647-30?

    The NDC Packaged Code 24450-647-30 is assigned to a package of 30 ml in 1 vial, multi-dose of Fludeoxyglucose F-18, a human prescription drug labeled by Brigham And Women`s Hospital, Inc., The. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 24450-647 included in the NDC Directory?

    Yes, Fludeoxyglucose F-18 with product code 24450-647 is active and included in the NDC Directory. The product was first marketed by Brigham And Women`s Hospital, Inc., The on October 30, 2014 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 24450-647-30?

    The 11-digit format is 24450064730. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-224450-647-305-4-224450-0647-30